Mayukh Sukhatme
Known title: President & CIOCIK: 0001750050
Associated companies
Transaction History
| ROIV | ▼ Sell | Tax Withholding | 46,879 | $1.7M | 9/30/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 144,756 | $557K | 8/21/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 144,756 | $5.3M | 8/21/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 17,519 | $67K | 8/20/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 17,519 | $653K | 8/20/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 172,899 | $666K | 8/19/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 172,899 | $6.4M | 8/19/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 31,801 | $122K | 8/18/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 105,141 | $405K | 8/18/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 31,801 | $1.2M | 8/18/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 105,141 | $3.8M | 8/18/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 284,707 | $1.1M | 8/17/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 284,707 | $10.3M | 8/17/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 243,177 | $936K | 8/14/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 243,177 | $8.8M | 8/14/2026 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 46,878 | $1.7M | 6/30/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 500,000 | $1.9M | 6/26/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 500,000 | $17.0M | 6/26/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 500,000 | $1.9M | 6/25/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 500,000 | $17.1M | 6/25/2026 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 187,512 | $5.2M | 3/31/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 58,391 | — | 3/30/2026 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 29,809 | $787K | 3/30/2026 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 651,558 | $8.3M | 2/9/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 339,441 | $9.0M | 2/9/2026 | View on chart |
| ROIV | ▼ Sell | Other | 312,117 | $8.3M | 2/9/2026 | View on chart |
| ROIV | ▼ Sell | Other | 1,430,882 | $31.1M | 12/31/2025 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 2,449,877 | $31.1M | 12/31/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 1,018,995 | $22.1M | 12/31/2025 | View on chart |
| ROIV | ▼ Sell | Other | 436,485 | $9.5M | 12/29/2025 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 748,358 | $9.5M | 12/29/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 311,873 | $6.8M | 12/29/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 26,831 | $620K | 12/17/2025 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 59,513 | $755K | 12/17/2025 | View on chart |
| ROIV | ▼ Sell | Other | 32,682 | $755K | 12/17/2025 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 689,495 | $2.7M | 12/26/2024 | View on chart |
| ROIV | ▼ Sell | Open Market | 689,495 | $8.3M | 12/26/2024 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 185,946 | $716K | 12/24/2024 | View on chart |
| ROIV | ▼ Sell | Open Market | 185,946 | $2.2M | 12/24/2024 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 10,796 | $42K | 12/23/2024 | View on chart |
| ROIV | ▼ Sell | Open Market | 10,796 | $130K | 12/23/2024 | View on chart |
| ROIV | ▼ Sell | Open Market | 412,584 | $5.0M | 12/18/2024 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 412,584 | $1.6M | 12/18/2024 | View on chart |
| ROIV | ▼ Sell | Other | 3,651,985 | $44.6M | 12/3/2024 | View on chart |
| ROIV | ▲ Buy | Grant | 17,000,000 | $0 | 7/26/2024 | View on chart |
| ROIV | ▲ Buy | Grant | 1,836,547 | $0 | 7/26/2024 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 729,081 | — | 3/30/2024 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 366,211 | $3.9M | 3/30/2024 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 71,365 | — | 12/27/2023 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 27,790 | — | 9/27/2023 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 22,565 | — | 8/27/2023 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 43,212 | — | 7/27/2023 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 99,458 | — | 5/27/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Roivant Sciences receives downgrades from Wolfe Research and analyst
Wolfe Research lowered Roivant Sciences to a peer‑perform rating. In the same week, an analyst who had been bullish on the company removed that stance, placing Roivant among a list of recent downgrades. The stock is now trading near its $28.03 support level with an RSI below 40, indicating limited upward momentum.
Roivant Sciences receives downgrades from Wolfe Research and analyst. Wolfe Research lowered Roivant Sciences to a peer‑perform rating. In the same week, an analyst who had been bullish on the company removed that stance, placing Roivant among a list of recent downgrades. The stock is now trading near its $28.03 support level with an RSI below 40, indicating limited upward momentum.